We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+0.39%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$69.6B
AUM Growth
+$2.44B
(+3.6%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
16.69%
Holding
760
New
59
Increased
405
Reduced
179
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American International
AIG
|
+$473M |
| 2 |
HP
HPQ
|
+$383M |
| 3 |
Occidental Petroleum
OXY
|
+$349M |
| 4 |
Target
TGT
|
+$343M |
| 5 |
Cigna
CI
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OCR
OMNICARE INC
OCR
|
+$333M |
| 2 |
LO
LORILLARD INC COM STK
LO
|
+$244M |
| 3 |
Marathon Petroleum
MPC
|
+$236M |
| 4 |
Home Depot
HD
|
+$201M |
| 5 |
AbbVie
ABBV
|
+$178M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.04% |
| 2 | Technology | 15.47% |
| 3 | Healthcare | 15.3% |
| 4 | Industrials | 11.92% |
| 5 | Consumer Discretionary | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Old Second Bancorp
OSBC
$1.24B
| $3.7M | 0.01% |
560,240
-920
| -0.2% | -$5.58K |
|
552
Freeport-McMoran
FCX
$90B
| $3.69M | 0.01% |
198,125
-400
| -0.2% | -$8.26K |
|
|
TIS
553
DELISTED
Orchids Paper Products, Inc.
TIS
| $3.67M | 0.01% |
+152,624
| New | +$3.59M |
|
554
Cognizant
CTSH
$21.5B
| $3.63M | 0.01% |
59,393
| – | – |
|
555
Iovance Biotherapeutics
IOVA
$2.23B
| $3.61M | 0.01% |
393,801
+202,832
| +106% | +$2.26M |
|
556
James River Group Holdings
JRVR
$218M
| $3.6M | 0.01% |
139,320
+1,000
| +0.7% | +$23.9K |
|
557
Independent Bank Corp
IBCP
$776M
| $3.6M | 0.01% |
265,470
-8,720
| -3% | -$116K |
|
|
FNSR
558
DELISTED
Finisar Corp
FNSR
| $3.57M | 0.01% |
199,558
-16,770
| -8% | -$356K |
|
559
Assurant
AIZ
$13.7B
| $3.55M | 0.01% |
53,050
+18,469
| +53% | +$1.19M |
|
|
LDR
560
DELISTED
Landauer Inc
LDR
| $3.53M | 0.01% |
+99,140
| New | +$3.38M |
|
561
Goodyear
GT
$2.07B
| $3.53M | 0.01% |
117,100
| – | – |
|
|
THOR
562
DELISTED
THORATEC CORPORATION
THOR
| $3.48M | 0.01% |
78,093
-626,121
| -89% | -$27.4M |
|
563
Global Industrial
GIC
$1.34B
| $3.45M | 0.01% |
399,207
-2,704
| -0.7% | -$26.3K |
|
564
Western Union
WU
$2.57B
| $3.41M | ﹤0.01% |
167,660
| – | – |
|
|
WX
565
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $3.38M | ﹤0.01% |
80,000
-40,000
| -33% | -$1.69M |
|
566
Ares Capital
ARCC
$13.5B
| $3.33M | ﹤0.01% |
202,443
+68,920
| +52% | +$1.15M |
|
567
Alibaba
BABA
$269B
| $3.33M | ﹤0.01% |
+40,422
| New | +$3.47M |
|
568
Commercial Metals
CMC
$7.63B
| $3.33M | ﹤0.01% |
206,802
| – | – |
|
569
Alpha and Omega Semiconductor
AOSL
$923M
| $3.32M | ﹤0.01% |
380,000
-42,616
| -10% | -$366K |
|
|
DEST
570
DELISTED
Destination Maternity Corporation
DEST
| $3.28M | ﹤0.01% |
281,160
+225,610
| +406% | +$2.8M |
|
571
Fastenal
FAST
$54B
| $3.27M | ﹤0.01% |
310,400
| – | – |
|
572
Omnicell
OMCL
$1.86B
| $3.24M | ﹤0.01% |
85,842
+630
| +0.7% | +$23K |
|
573
Sunstone Hotel Investors
SHO
$2.19B
| $3.23M | ﹤0.01% |
+215,290
| New | +$3.38M |
|
574
Genesco
GCO
$396M
| $3.22M | ﹤0.01% |
48,796
+14,458
| +42% | +$992K |
|
575
MYR Group
MYRG
$5.9B
| $3.2M | ﹤0.01% |
103,340
-75,580
| -42% | -$2.27M |
|
Similar funds
Boston Partners's Q2 2015 Portfolio in Review
As of Q2 2015, Boston Partners held 760 positions worth $69.6B, up 3.6% from $67.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners deployed $2.78B of net new capital in Q2 2015, opening 59 new positions and adding to 405 existing holdings. Its largest new stake was Target: 4,243,475 shares worth $346M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was OMNICARE INC, an estimated $333M trimmed.
- Boston Partners's largest Q2 2015 buy was Target: 4,243,475 shares worth $346M.
- Boston Partners added most to American International in Q2 2015, an estimated $473M increase.
- Boston Partners's biggest Q2 2015 reduction was OMNICARE INC, cutting an estimated $333M.
- Boston Partners fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $244M.
- Boston Partners's ten largest holdings make up 17% of its $69.6B portfolio in Q2 2015.
- Boston Partners opened 59 new positions and closed 58 in Q2 2015.
- Boston Partners's portfolio value rose 3.6% quarter-over-quarter to $69.6B.
Based on Boston Partners's 13F filing for Q2 2015, filed 10 Aug 2015.